• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过重组DNA技术获得的人组织型纤溶酶原激活剂产量增加。

Increased yield of human tissue-type plasminogen activator obtained by means of recombinant DNA technology.

作者信息

Browne M J, Dodd I, Carey J E, Chapman C G, Robinson J H

出版信息

Thromb Haemost. 1985 Aug 30;54(2):422-4.

PMID:3936214
Abstract

Extra copies of the human tissue-type plasminogen activator (t-PA) gene were introduced into the Bowes melanoma cell line. We obtained a recombinant cell line (TRBM6) which secretes approximately ten-fold more t-PA than the parent cell line. The identity of the plasminogen activator made by the new cell line was confirmed by sizing on sodium dodecyl sulphate polyacrylamide gels and by specific quenching using anti-t-PA antibody. We estimate that the recombinant line produces t-PA at a rate of approximately 3 pg/cell/24 hr and that t-PA accumulates in the harvest medium at a rate of approximately 4000 International t-PA Units/ml/24 hr.

摘要

将人组织型纤溶酶原激活剂(t-PA)基因的额外拷贝导入鲍伊斯黑色素瘤细胞系。我们获得了一个重组细胞系(TRBM6),其分泌的t-PA比亲本细胞系多大约十倍。通过十二烷基硫酸钠聚丙烯酰胺凝胶电泳测定大小以及使用抗t-PA抗体进行特异性淬灭,证实了新细胞系产生的纤溶酶原激活剂的特性。我们估计重组细胞系产生t-PA的速率约为3 pg/细胞/24小时,并且t-PA在收获培养基中的积累速率约为4000国际单位t-PA/毫升/24小时。

相似文献

1
Increased yield of human tissue-type plasminogen activator obtained by means of recombinant DNA technology.通过重组DNA技术获得的人组织型纤溶酶原激活剂产量增加。
Thromb Haemost. 1985 Aug 30;54(2):422-4.
2
The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.通过生成包含与蛋白酶结构域相连的每个kringle的重组分子所揭示的kringle 1和kringle 2在重组组织型纤溶酶原激活剂酶学性质中的效应作用。
Arch Biochem Biophys. 1993 Jan;300(1):472-82. doi: 10.1006/abbi.1993.1064.
3
Expression of human tissue-type plasminogen activator from lytic viral vectors and in established cell lines.
Mol Biol Med. 1986 Dec;3(6):459-81.
4
Isolation and preliminary characterisation of active B-chain of recombinant tissue-type plasminogen activator.重组组织型纤溶酶原激活剂活性B链的分离及初步鉴定
Thromb Haemost. 1986 Feb 28;55(1):94-7.
5
The tissue-type plasminogen activator story.组织型纤溶酶原激活剂的故事。
Arterioscler Thromb Vasc Biol. 2009 Aug;29(8):1151-5. doi: 10.1161/ATVBAHA.108.179655.
6
Isolation, identification and pharmacokinetic properties of human tissue-type plasminogen activator species: possible localisation of a clearance recognition site.人组织型纤溶酶原激活剂异构体的分离、鉴定及药代动力学特性:清除识别位点的可能定位
Thromb Haemost. 1988 Jun 16;59(3):523-8.
7
Modulation of murine B16F10 melanoma plasminogen activator production by a synthetic peptide derived from the laminin A chain.源自层粘连蛋白A链的合成肽对小鼠B16F10黑色素瘤纤溶酶原激活物产生的调节作用。
Cancer Res. 1993 May 1;53(9):1998-2004.
8
Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli.编码人组织型纤溶酶原激活剂的cDNA克隆及其在大肠杆菌中的表达。
Mol Biol Med. 1986 Jun;3(3):279-92.
9
A collaborative study to establish the 2nd international standard for tissue plasminogen activator (t-PA).一项建立组织型纤溶酶原激活剂(t-PA)第二个国际标准的合作研究。
Thromb Haemost. 1987 Dec 18;58(4):1085-7.
10
Expression of plasminogen activators and plasminogen activator inhibitors in cutaneous melanomas of transgenic melanoma-susceptible mice.转基因黑色素瘤易感小鼠皮肤黑色素瘤中纤溶酶原激活剂和纤溶酶原激活剂抑制剂的表达
Cancer Res. 1995 Oct 15;55(20):4681-7.

引用本文的文献

1
The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.链激酶 - 纤溶酶原激活物复合物、组织型纤溶酶原激活物、尿激酶及其酰化衍生物与纤维蛋白及纤维蛋白原溴化氰消化产物的相互作用。与体外纤溶活性的关系。
Biochem J. 1987 Oct 15;247(2):395-400. doi: 10.1042/bj2470395.
2
A novel in vivo transcription assay demonstrates the presence of globin-inducing trans-acting factors in uninduced murine erythroleukemia cells.一种新型的体内转录试验证明,在未诱导的小鼠红白血病细胞中存在诱导珠蛋白的反式作用因子。
Mol Cell Biol. 1988 Jan;8(1):130-7. doi: 10.1128/mcb.8.1.130-137.1988.
3
An active-site titrant for human tissue-type plasminogen activator.
一种用于人组织型纤溶酶原激活剂的活性位点滴定剂。
Biochem J. 1986 Oct 15;239(2):477-9. doi: 10.1042/bj2390477.
4
Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.组织型纤溶酶原激活物的指状结构域和kringle 2结构域参与纤维蛋白结合及纤维蛋白对其活性的刺激作用。
EMBO J. 1986 Dec 20;5(13):3525-30. doi: 10.1002/j.1460-2075.1986.tb04678.x.
5
Reagents for reversible coupling of proteins to the active centres of trypsin-like serine proteinases.用于蛋白质与类胰蛋白酶丝氨酸蛋白酶活性中心可逆偶联的试剂。
Biochem J. 1987 Dec 1;248(2):409-13. doi: 10.1042/bj2480409.
6
Kinetic studies on novel plasminogen activators. Demonstration of fibrin enhancement for hybrid enzymes comprising the A-chain of plasmin (Lys-78) and B-chain of tissue-type plasminogen activator (Ile-276) or urokinase (Ile-159).新型纤溶酶原激活剂的动力学研究。包含纤溶酶A链(Lys-78)与组织型纤溶酶原激活剂B链(Ile-276)或尿激酶B链(Ile-159)的杂合酶的纤维蛋白增强作用证明。
Biochem J. 1990 Mar 15;266(3):693-6. doi: 10.1042/bj2660693.